Immunic Inc (NASDAQ:IMUX) announced it will participate in investor conferences: Leerink Partners Global Biopharma Conference and Frontiers in Medicinal Chemistry, showcasing research on oral therapies for inflammatory diseases.
Additionally, they will present at the 33rd Annual Meeting of the Society for Virology, focusing on antiviral small molecule inhibitors. Visit their website for event details: https://ir.imux.com/events-and-presentations.